OLDAKOWSKI MARK 4

What Happened
Mark Oldakowski, Chief Operating Officer of Bionano Genomics (BNGO), had 20 shares of common stock withheld by the issuer to satisfy tax withholding obligations tied to an RSU settlement. The withholding is reported as a disposition (code F) at $1.10 per share for a total value of $22. This was not an open‑market sale but a retention of shares by the company to cover taxes upon vesting.

Key Details

• Transaction date and price: 2026-02-17 — 20 shares withheld @ $1.10 per share (total $22).
• Shares owned after transaction: Not specified in the provided summary; see the filed Form 4 for post-transaction holdings.
• Footnote: The 20 shares were withheld in connection with RSUs that vested on Feb 15, 2026 from an award granted Feb 15, 2023; shares were not issued in order to satisfy tax withholding.
• Filing timeliness: Report filed 2026-02-18 for a 2026-02-17 transaction — appears to be timely.
• Transaction code: F = tax withholding (not a purchase or market sale).

Context
This is a routine net‑settlement/tax withholding of vested RSUs, not a discretionary sale or purchase by the insider. The economic impact is minimal ($22) and generally should not be interpreted as a buy/sell signal about the company. For complete details (including holdings after the transaction), consult the full Form 4 (Accession 0001745566-26-000004).